Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 197.01

-2.9%

Dec 1 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (9609)	10/20/1997 11:59:00 AM
From: Henry Niman	of 32384

Andy, I think that you are misreading the press release. LGND did NOT give up Targretin rights for cancer "Ligand retains exclusive rights to independently research, develop, and commercialize Targretin and othe RXR compounds in the fields of cancer and dermatology." The also only gave up the leptin promoter program (as predicted), not the leptin signaling program, which SA indicated was another strategic alliance (which I suspect will be announced soon).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next